Related Experiment Video
Updated: Mar 27, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
Staphylococcus aureus bacteremic pneumonia
C De la Calle1, L Morata2, N Cobos-Trigueros2
1Department of Infectious Diseases Hospital Clínic, Barcelona, Spain. DELACALLE@CLINIC.UB.ES.
Abstract:
Staphylococcus aureus bacteremic pneumonia is an uncommon cause of hospitalization, with a high mortality rate. However, published reports are scarce and have included a small number of cases. All patients with S. aureus bacteremic pneumonia were prospectively collected in our institution from 2000 to 2014, and a retrospective revision was performed to identify risk factors associated with methicillin resistance and to update the mortality of this entity. A total of 98 patients were admitted: 57.1 % were due to methicillin-susceptible S. aureus (MSSA) and 42.8 % due to methicillin-resistant S. aureus (MRSA). In 40 patients (40.8 %), the infection was community acquired. Thirteen were ventilator-associated pneumonia episodes. The most frequent comorbidities were chronic lung disease (34.7 %), chronic renal failure (31.6 %), diabetes mellitus (29.6 %), and cardiovascular disease (31.6 %). Septic shock was present in 46 patients (46.9 %). The 30-day mortality was 46.9 %. MRSA infections occurred in older patients, more frequently with cardiovascular diseases, and they had received antibiotic treatment in the previous month more often than MSSA-infected patients. Patients with infection due to MSSA presented more frequently with septic shock, but they received more frequently appropriate empirical antibiotic therapy than patients with MRSA pneumonia (96 % vs. 38.1 %), and no differences in mortality were observed between both groups. In conclusion, S. aureus bacteremic pneumonia is a severe infection that, nowadays, affects people with comorbidities and the mortality is still high.
Insights
Staphylococcus aureus bacteremic pneumonia is a severe infection with a high mortality rate, often affecting patients with underlying health conditions. This study highlights the persistent high mortality and identifies risk factors for methicillin resistance.
Area of Science:
- Infectious Diseases
- Pulmonology
- Critical Care Medicine
Background:
- Staphylococcus aureus bacteremic pneumonia is an uncommon but severe condition with scarce published data.
- High mortality rates underscore the need for updated epidemiological and risk factor analysis.
Purpose of the Study:
- To identify risk factors associated with methicillin resistance in Staphylococcus aureus bacteremic pneumonia.
- To update the current mortality rates for this infection.
Main Methods:
- Prospective collection of patients with S. aureus bacteremic pneumonia from 2000 to 2014.
- Retrospective analysis to identify risk factors and compare outcomes between methicillin-susceptible (MSSA) and methicillin-resistant (MRSA) strains.
Main Results:
- A total of 98 patients were included; 40.8% had community-acquired infections.
- Frequent comorbidities included chronic lung disease, renal failure, diabetes, and cardiovascular disease.
- Overall 30-day mortality was 46.9%. MRSA infections occurred in older patients with more cardiovascular disease and prior antibiotic exposure.
Conclusions:
- Staphylococcus aureus bacteremic pneumonia remains a severe infection with high mortality, particularly in patients with comorbidities.
- While MSSA infections presented with more septic shock, appropriate empirical antibiotic therapy was more common than for MRSA.
- No significant difference in mortality was observed between MSSA and MRSA infections.
More Related Videos
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Staphylococcal Skin Infections
Atypical Pneumonia
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Mechanism of Antibiotic Resistance in MRSA

